Mouse models as tools to explore cytidine-to-uridine RNA editing.
暂无分享,去创建一个
[1] Robert V Farese,et al. Targeted Disruption of the Mouse apobec-1 Gene Abolishes Apolipoprotein B mRNA Editing and Eliminates Apolipoprotein B48 (*) , 1996, The Journal of Biological Chemistry.
[2] J. Scott,et al. Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B messenger RNA. , 1988, The Journal of biological chemistry.
[3] R. Pease,et al. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine , 1987, Cell.
[4] R. Davis,et al. Dietary carbohydrate induces lipogenesis and very-low-density lipoprotein synthesis. , 1984, The American journal of physiology.
[5] K. Kitagawa,et al. Developmental and age-related changes in apolipoprotein B mRNA editing in mice. , 1992, Journal of lipid research.
[6] N. Davidson,et al. REPR and complementation factor(s) interact to modulate rat apolipoprotein B mRNA editing in response to alterations in cellular cholesterol flux. , 1994, Journal of lipid research.
[7] R. König,et al. Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif , 2003, Cell.
[8] N. Sherman,et al. Molecular Cloning of Apobec-1 Complementation Factor, a Novel RNA-Binding Protein Involved in the Editing of Apolipoprotein B mRNA , 2000, Molecular and Cellular Biology.
[9] G. Ness,et al. Thyroid hormone rapidly induces hepatic LDL receptor mRNA levels in hypophysectomized rats. , 1994, Archives of biochemistry and biophysics.
[10] Nicholas O. Davidson,et al. C-to-U RNA Editing: Mechanisms Leading to Genetic Diversity* , 2003, The Journal of Biological Chemistry.
[11] T. Innerarity,et al. A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. , 1997, Genes & development.
[12] N. Davidson,et al. Tissue-specific, developmental and nutritional regulation of the gene encoding the catalytic subunit of the rat apolipoprotein B mRNA editing enzyme: functional role in the modulation of apoB mRNA editing. , 1995, Journal of lipid research.
[13] F. Buck,et al. Purification and Molecular Cloning of a Novel Essential Component of the Apolipoprotein B mRNA Editing Enzyme-Complex* , 2000, The Journal of Biological Chemistry.
[14] M. Sowden,et al. Metabolic regulation of ApoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor , 2006, Nucleic acids research.
[15] D. Viskochil,et al. C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme. , 2002, American journal of human genetics.
[16] K. Grapperhaus,et al. Ontogenic regulation of spatial differentiation in the crypt-villus axis of normal and isografted small intestine. , 1995, The American journal of physiology.
[17] N. Davidson,et al. Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[18] S. Kihara,et al. Increased proportion of plasma apoB-48 to apoB-100 in non-insulin-dependent diabetic rats: contribution of enhanced apoB mRNA editing in the liver. , 1995, Journal of lipid research.
[19] D. Cahill,et al. Ethanol modulates apolipoprotein B mRNA editing in the rat. , 1995, Journal of lipid research.
[20] R. Davis,et al. Intrahepatic assembly of very low density lipoproteins. Varied synthetic response of individual apolipoproteins to fasting. , 1985, The Journal of biological chemistry.
[21] J. Taylor,et al. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[22] B. Chang,et al. Complete Phenotypic Characterization of apobec-1 Knockout Mice with a Wild-type Genetic Background and a Human Apolipoprotein B Transgenic Background, and Restoration of Apolipoprotein B mRNA Editing by Somatic Gene Transfer of Apobec-1* , 1996, The Journal of Biological Chemistry.
[23] G. Skuse,et al. A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors. , 1997, American journal of human genetics.
[24] T. Honjo,et al. Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.
[25] M. Elam,et al. Stimulation of in vitro triglyceride synthesis in the rat hepatocyte by growth hormone treatment in vivo. , 1988, Endocrinology.
[26] Ahmed Mansouri,et al. Congenital hypothyroid Pax8(-/-) mutant mice can be rescued by inactivating the TRalpha gene. , 2002, Molecular endocrinology.
[27] S. Kennedy,et al. A Novel Nuclear Localization Signal in the Auxiliary Domain of Apobec-1 Complementation Factor Regulates Nucleocytoplasmic Import and Shuttling* , 2003, Journal of Biological Chemistry.
[28] M. Perugini,et al. Structural features of apolipoprotein B synthetic peptides that inhibit lipoprotein(a) assembly Published, JLR Papers in Press, September 16, 2004. DOI 10.1194/jlr.M400163-JLR200 , 2004, Journal of Lipid Research.
[29] R. A. Srivastava. Increased apoB100 mRNA in inbred strains of mice by estrogen is caused by decreased RNA editing protein mRNA. , 1995, Biochemical and biophysical research communications.
[30] S. Young,et al. Genetically modified mice for the study of apolipoprotein B. , 1998, Journal of lipid research.
[31] V. Blanc,et al. Isolation, characterization and developmental regulation of the human apobec-1 complementation factor (ACF) gene. , 2001, Biochimica et biophysica acta.
[32] Wolf Reik,et al. Mice Deficient in APOBEC2 and APOBEC3 , 2005, Molecular and Cellular Biology.
[33] N. Davidson,et al. Apolipoprotein B messenger RNA editing is developmentally regulated in pig small intestine: nucleotide comparison of apolipoprotein B editing regions in five species. , 1990, Biochemical and biophysical research communications.
[34] J. Borén,et al. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[35] D. Mukhopadhyay,et al. Thyroid hormone regulates hepatic triglyceride mobilization and apolipoprotein B messenger ribonucleic Acid editing in a murine model of congenital hypothyroidism. , 2003, Endocrinology.
[36] N. Davidson,et al. APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation. , 2000, Annual review of nutrition.
[37] T. Innerarity,et al. Hyperediting of Multiple Cytidines of Apolipoprotein B mRNA by APOBEC-1 Requires Auxiliary Protein(s) but Not a Mooring Sequence Motif (*) , 1996, The Journal of Biological Chemistry.
[38] S. Olofsson,et al. Effects of growth hormone on apolipoprotein-B (apoB) messenger ribonucleic acid editing, and apoB 48 and apoB 100 synthesis and secretion in the rat liver. , 1992, Endocrinology.
[39] H. Brewer,et al. Developmental Regulation of Apolipoprotein B mRNA Editing Is an Autonomous Function of Small Intestine Involving Homeobox Gene Cdx1* , 2003, The Journal of Biological Chemistry.
[40] N. Davidson,et al. Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro. , 1998, Journal of lipid research.
[41] C. Burant,et al. Molecular cloning of an apolipoprotein B messenger RNA editing protein. , 1993, Science.
[42] R. Hammer,et al. Transgenic Mice Expressing Human ApoB95 and ApoB97 , 1997, The Journal of Biological Chemistry.
[43] D. Mukhopadhyay,et al. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing. , 2001, American journal of physiology. Cell physiology.
[44] B. Mccarthy,et al. Elimination of apolipoprotein B48 formation in rat hepatoma cell lines transfected with mutant human apolipoprotein B cDNA constructs. , 1992, The Journal of biological chemistry.
[45] N. Navaratnam,et al. Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. , 1994, The Journal of biological chemistry.
[46] H. Greten,et al. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. , 1993, Journal of lipid research.
[47] Hui Zhu,et al. Apolipoprotein B mRNA editing is an intranuclear event that occurs posttranscriptionally coincident with splicing and polyadenylation. , 1991, The Journal of biological chemistry.
[48] S. Kennedy,et al. Targeted Deletion of the Murine apobec-1 Complementation Factor (acf) Gene Results in Embryonic Lethality , 2005, Molecular and Cellular Biology.
[49] N. Davidson,et al. Apolipoprotein B messenger RNA editing in the rat liver. Modulation by fasting and refeeding a high carbohydrate diet. , 1990, The Journal of biological chemistry.
[50] N. Ballatori,et al. The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors. , 2002, Journal of cell science.
[51] Z W Gu,et al. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. , 1987, Science.
[52] H. Hobbs,et al. Expression of human apolipoprotein B90 in transgenic mice. Demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein. , 1994, The Journal of biological chemistry.
[53] M. Hersberger,et al. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting. , 2003, The Biochemical journal.
[54] S. Marcovina,et al. Mutation of lysine residues in apolipoprotein B-100 causes defective lipoprotein[a] formation Published, JLR Papers in Press, September 16, 2003. DOI 10.1194/jlr.M300071-JLR200 , 2004, Journal of Lipid Research.
[55] L. Chan,et al. APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family. , 1999, Biochemical and biophysical research communications.
[56] C. Burant,et al. Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B48. , 1994, The Journal of biological chemistry.
[57] M. Sowden,et al. Regulation of hepatic apolipoprotein B RNA editing in the genetically obese Zucker rat. , 1996, Metabolism: clinical and experimental.
[58] R. Davis,et al. Fasting decreases apolipoprotein B mRNA editing and the secretion of small molecular weight apoB by rat hepatocytes: evidence that the total amount of apoB secreted is regulated post-transcriptionally. , 1990, Journal of lipid research.
[59] M. Seishima,et al. Regulation of hepatic apolipoprotein synthesis in the 17 alpha-ethinyl estradiol-treated rat. , 1991, Journal of lipid research.
[60] J. Samarut,et al. Involvement of T3Rα- and β-receptor subtypes in mediation of T3 functions during postnatal murine intestinal development , 1999 .
[61] J. Morrison,et al. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[62] K. Weisgraber,et al. The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia. , 1992, The Journal of biological chemistry.
[63] W. Li,et al. Apolipoprotein B mRNA editing. Validation of a sensitive assay and developmental biology of RNA editing in the rat. , 1990, The Journal of biological chemistry.
[64] N. Kakazu,et al. Constitutive Expression of AID Leads to Tumorigenesis , 2003, The Journal of experimental medicine.
[65] R. Davis,et al. Intrahepatic assembly of very low density lipoproteins. Effect of fatty acids on triacylglycerol and apolipoprotein synthesis. , 1982, The Journal of biological chemistry.
[66] S. Kennedy,et al. Mutagenesis of Apobec-1 Complementation Factor Reveals Distinct Domains That Modulate RNA Binding, Protein-Protein Interaction with Apobec-1, and Complementation of C to U RNA-editing Activity* , 2001, The Journal of Biological Chemistry.
[67] R. Raghow,et al. Insulin promotes the biosynthesis and secretion of apolipoprotein B-48 by altering apolipoprotein B mRNA editing. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[68] N. Davidson,et al. Apolipoprotein B messenger RNA editing is developmentally regulated and widely expressed in human tissues. , 1990, The Journal of biological chemistry.
[69] N. Davidson,et al. Insulin increases expression of apobec-1, the catalytic subunit of the apolipoprotein B mRNA editing complex in rat hepatocytes. , 1998, Metabolism: clinical and experimental.
[70] S. Young,et al. Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. , 1997, The Journal of clinical investigation.
[71] T. Honjo,et al. Specific Expression of Activation-induced Cytidine Deaminase (AID), a Novel Member of the RNA-editing Deaminase Family in Germinal Center B Cells* , 1999, The Journal of Biological Chemistry.